© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
November 01, 2019
At AMCP NEXUS 2019, Susan Trieu, PharmD, director of Enterprise Specialty Clinical Solutions for MedImpact Healthcare Systems, Inc, predicts the top specialty drug categories that will be driving spend in 2020.
October 26, 2019
How can payers appropriately plan and manage benefit coverage with so many expensive specialty drugs coming down the pipeline?
October 25, 2019
As more biosimilar drugs gain approval, managed care organizations need to consider how to best utilize them for optimal savings.
As more of the healthcare industry moves to value-based contracts, it is imperative that managed care organizations can successfully measure outcomes.
With the proposed rebate rule now withdrawn, what will Congress do to help curb drug spend?
October 19, 2019
As digital health and therapeutic capabilities continue to grow, it is vital that managed care organizations keep one eye toward the future.
October 26, 2018
Biosimilars hold great cost savings promises for payers and patients alike-but only if prescribers and patients are willing to make the switch.
Good leaders don’t just rely on one managerial style-they get the best out of every team member by meeting their needs.
October 25, 2018
Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.
Better care at lower costs is the ultimate goal across healthcare today. Here’s how pharmacists can help.